Biosimilar Red Tape Elimination Act

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 1954 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 1954 To improve the requirements for making a determination of interchangeability of a biological product and its reference product. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES June 4, 2025 Mr. Lee (for himself, Mr. Lujan, Mr. Paul, and Ms. Hassan) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Biosimilar Red Tape Elimination Act''. SEC. 2. BIOSIMILAR BIOLOGICAL PRODUCTS. (a) In General.--Section 351(k) of the Public Health Service Act (42 U.S.C. 262(k)) is amended-- (1) in the subsection heading, by striking ``or Interc…